Atlas Trials

A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

Clinical trial NCT06782594 · RECRUITING

Trial details

NCT number
NCT06782594
Sponsor
Shandong New Time Pharmaceutical Co., LTD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Postoperative Gastrointestinal Dysfunction
Start date
2024-10-18
Primary completion
2025-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.